Leserbrief zum Beitrag: Ist Hormontherapie bei Hodenhochstand noch zeitgemäß? Aktuelle Urologie 2020; 51: 183 – 185

Faruk Hadziselimovic; Burkhard Höcht

doi:10.1055/a-1170-6109

Aktuelle Urologie, Table of Contents

Aktuelle Urol 2020; 51(03): 244-247
DOI: 10.1055/a-1170-6109

Leserbrief

Leserbrief zum Beitrag: Ist Hormontherapie bei Hodenhochstand noch zeitgemäß? Aktuelle Urologie 2020; 51: 183 – 185

Faruk Hadziselimovic

Institut für Kryptorchismus Forschung, Kindermedizinisches Zentrum Liestal

,

Burkhard Höcht

Institut für Kryptorchismus Forschung, Kindermedizinisches Zentrum Liestal

› Author Affiliations

Abstract

Full Text

References

Literatur
1 Hadziselimovic F, Herzog B, Seguchi H. Surgical correction of cryptorchidism at 2 years: electron microscopic and morphometric investigations. J Pedaitr Surg 1975; 10: 19-26
2 Hadziselimovic F, Herzog B. Hodenerkrankungen im Kindesalter. Bibliothek für Kinderheilkunde. Stuttgart: Hippokrates Verlag; 1990. ISBN: 3-7773-0929-X
3 Hadziselimovic F, Hoecht B. Testicular histology related to fertility outcome and postpubertal hormone status in cryptorchidism. Klin Padiatr 2008; 220: 302-307
4 Hadziselimovic F, Hoecht B, Herzog B. et al. Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy. Horm Res 2007; 68: 46-52
5 Hadziselimovic F. Successful treatment of unilateral cryptorchid boys risking infertility with LH-RH analogue. Int Braz J Urol 2008; 34 (03) 319-328
6 Dunkel L. et al. Cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J Clin Invest 1997; 100: 2341-2346
7 Cortes D, Thorup J, Visfeldt J. Hormonal treatment may harm the germ cells in 1 to 3-year-old boys with cryptorchidism. J Urol 2000; 163: 1290-1292
8 Zivkovic D, Bica DG, Hadziselimovic F. Effects of hormonal treatment on the contralateral descended testis in unilateral cryptorchidism. J Pediatr Urol 2006; 2: 468-472
9 Hadziselimovic F, Huff D, Duckett J. et al. Treatment of cryptorchidism with low doses of buserelin over a 6-month period. Eur J Pediatr 1987 Oct;138(4 Pt 2):1043-5. doi: 10.1016/s0022-5347(17)43495-1. PMID: 2888905.
10 Schröder A. Hormonal therapy for undescended testes: an outdated concept?. Aktuelle Urol 2020; 51: 183-185
11 Hadziselimovic F. On descent of epididymo-testicular unit, cryptorchidism, and prevention of infertility. Basic Clin Androl 2017; 27: 21
12 De Muinck Keizer-Schrama SM, Hazebroek FW, Matroos AW. et al. Double-blind, placebo-controlled study of luteinizing-hormone-releasing-hormone nasal spray in treatment of undescended testes. Lancet 1986; 1: 876-880
13 Borkenstein M, Zobel V. Treatment of cryptorchidism with LHRH nasal spray. Wien Klin Wochenschr 1985; 97: 414-416
14 Hagberg S, Westphal O. Results of combined hormonal and surgical treatment for undescended testis in boys under 3 years of age. A randomized study. Eur J Pediatr 1987; 146: 38-39
15 Höcht B. Therapy of prepubertal cryptorchidism. Clinical experiences with LH-RH treatment. Fortschr Med 1983; 101: 1531-1535
16 Bica DT, Hadziselimovic F. Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study. J Urol 1992; 148: 617-621